BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18655152)

  • 1. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
    Spensberger D; Delwel R
    FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
    Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
    Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR.
    Kamoi K; Yamamoto K; Misawa A; Miyake A; Ishida T; Tanaka Y; Mochizuki M; Watanabe T
    Retrovirology; 2006 Jan; 3():5. PubMed ID: 16409643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.
    Chakraborty S; Sinha KK; Senyuk V; Nucifora G
    Oncogene; 2003 Aug; 22(34):5229-37. PubMed ID: 12917624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.
    Marban C; Suzanne S; Dequiedt F; de Walque S; Redel L; Van Lint C; Aunis D; Rohr O
    EMBO J; 2007 Jan; 26(2):412-23. PubMed ID: 17245431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization.
    Goyama S; Nitta E; Yoshino T; Kako S; Watanabe-Okochi N; Shimabe M; Imai Y; Takahashi K; Kurokawa M
    Leukemia; 2010 Jan; 24(1):81-8. PubMed ID: 19776757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription.
    Reed-Inderbitzin E; Moreno-Miralles I; Vanden-Eynden SK; Xie J; Lutterbach B; Durst-Goodwin KL; Luce KS; Irvin BJ; Cleary ML; Brandt SJ; Hiebert SW
    Oncogene; 2006 Sep; 25(42):5777-86. PubMed ID: 16652147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression.
    Boulias K; Talianidis I
    Nucleic Acids Res; 2004; 32(20):6096-103. PubMed ID: 15550569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
    Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
    Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
    Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
    Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
    Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
    Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated histone modifications mediated by a CtBP co-repressor complex.
    Shi Y; Sawada J; Sui G; Affar el B; Whetstine JR; Lan F; Ogawa H; Luke MP; Nakatani Y; Shi Y
    Nature; 2003 Apr; 422(6933):735-8. PubMed ID: 12700765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of chromatin structure by site-specific histone H3 methyltransferases.
    Rea S; Eisenhaber F; O'Carroll D; Strahl BD; Sun ZW; Schmid M; Opravil S; Mechtler K; Ponting CP; Allis CD; Jenuwein T
    Nature; 2000 Aug; 406(6796):593-9. PubMed ID: 10949293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
    Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
    Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain.
    Krouwels IM; Wiesmeijer K; Abraham TE; Molenaar C; Verwoerd NP; Tanke HJ; Dirks RW
    J Cell Biol; 2005 Aug; 170(4):537-49. PubMed ID: 16103223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.